Acute Myeloid Leukemia in Qatar (2010–2016): Clinical, Biological, and Prognostic Factors and Treatment Outcomes-Reference-Cited by-同舟云学术

Acute Myeloid Leukemia in Qatar (2010–2016): Clinical, Biological, and Prognostic Factors and Treatment Outcomes

Published:2020-06-17 Issue: Volume:11 Page:
ISSN:1664-8021
Container-title:Frontiers in Genetics
language:
Short-container-title:Front. Genet.

Author:

El Omri Halima,Taha Ruba Yasin,Elomri Adel,Kacem Nancy,Elsabah Hesham,Ellahie Anil Yousaf,Gamil Amna,Ibrahim Firyal,Soliman Dina Sameh Abdelrahman,El Akiki Susanna Jane Lawson,Nawaz Zafar,Al Sabbagh Ahmad,El Omri Abdelfatteh

Funder

Qatar National Research Fund

Publisher

Frontiers Media SA

Subject

Genetics(clinical),Genetics,Molecular Medicine

Reference39 articles.

1. Age and acute myeloid leukemia.;Appelbaum;Blood,2006

2. Further correlations of morphology according to FAB and WHO classification to cytogenetics in de novo acute myeloid leukemia: a study on 2,235 patients.;Bacher;Ann. Hematol.,2005

3. Acute myeloid leukemia (AML): different treatment strategies versus a common standard arm—combined prospective analysis by the German AML intergroup.;Büchner;J. Clin. Oncol.,2012

4. Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the Medical Research Council AML15 trial.;Burnett;J. Clin. Oncol.,2013

5. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461).;Byrd;Blood,2002

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of three different methods for detection Pneumocystis jirovecii compared with immuno-fluorescence technique among patients with hematological malignancies and febrile neutropenia;AIP Conference Proceedings;2024

2. A Survival Analysis of Acute Myeloid Leukemia Patients Treated With Intensive Chemotherapy: A Single Center Experience;Cureus;2023-08-20

3. SETD2 detection may reveal response to induction therapy and survival profile in acute myeloid leukemia patients;Hematology;2023-01-06

4. Cytogenetics analysis as the central point of genetic testing in acute myeloid leukemia (AML): a laboratory perspective for clinical applications;Clinical and Experimental Medicine;2022-10-13

5. SMPDL3B Predicts Poor Prognosis and Contributes to Development of Acute Myeloid Leukemia;Frontiers in Molecular Biosciences;2021-08-24